Belmont, MA, United States of America

Jill P Mesirov

This inventor holds 4 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Whitehead Institute for Biomedical Research, The Broad Institute, Inc.. Active years: 2003-2017.


% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 96(Granted Patents)


Company Filing History:


Years Active: 2003-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Inventor Jill P Mesirov

Introduction:

Jill P Mesirov, a talented inventor hailing from Belmont, MA (US), has made significant contributions in the field of cancer research and biomarker detection. With a total of 4 patents to his name, Jill Mesirov continues to push the boundaries of innovation in the healthcare industry.

Latest Patents:

1. "Signatures and determinants associated with cancer and methods of use thereof": This patent focuses on methods of detecting cancer using biomarkers, allowing for more precise and early diagnosis.

2. "Methods for predicting chemosensitivity or chemoresistance": These methods involve classifying or predicting the classes for samples based on gene expression, aiding in determining treatment sensitivity or resistance.

Career Highlights:

Jill Mesirov has made valuable contributions while working at esteemed institutions such as the Dana-Farber Cancer Institute and the Whitehead Institute for Biomedical Research. His expertise has been instrumental in advancing cancer research and treatment methodologies.

Collaborations:

Throughout his career, Jill Mesirov has collaborated with renowned professionals in the field, including Pablo Tamayo and Todd R Golub. Together, they have worked on groundbreaking projects that have helped shape the future of cancer diagnostics and personalized medicine.

Conclusion:

Inventor Jill P Mesirov's dedication to innovation and his relentless pursuit of scientific excellence have established him as a key figure in the realm of cancer research. His patents and collaborative efforts serve as a testament to his unwavering commitment to improving healthcare outcomes and advancements in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…